Navigation Links
Gladstone's Shinya Yamanaka wins prestigious Shaw Prize
Date:6/11/2008

SAN FRANCISCO, CA June 11, 2008 The J. David Gladstone Institutes today announced that senior investigator Shinya Yamanaka, MD, PhD, also of Kyoto University and UCSF, has been awarded the prestigious Shaw Prize for his contributions in reprogramming adult skin cells to pluripotent, embryonic-like stem cells. He will receive half of the $1 million award. Cloning pioneers Ian Wilmut and Keith Campbell will split the other half of the prize for their landmark generation of the now famous sheep, Dolly.

"Dr. Yamanaka's discoveries have dramatically accelerated the pace of stem cell research and the development of this technology for regenerative therapies," said Gladstone president Robert W. Mahley, MD, PhD. "We're proud that our colleague has received this international honor."

Dr. Yamanaka and his Kyoto University laboratory demonstrated in 2006 that the addition of just four genes could convert adult mouse skin cells back to embryonic-like stem cells, which he called induced pluripotent stem (iPS) cells. The iPS cells could turn into all of the different cell types of the body and appeared to have the same properties as embryonic stem cells. Importantly, the pluripotent cells were made without the need to generate an embryo, obviating many of the ethical concerns around stem cell biology. Then in 2007, Dr. Yamanaka's laboratory created iPS cells from human skin cells in a similar fashion. Dr. Yamanaka's discoveries have opened a new field of science and represent a quantum leap forward in stem cell biology.

The Shaw Prize, established under the auspices of Mr. Run Run Shaw in November 2002, is an international award to honor individuals who are currently active in their respective fields and who have made outstanding contributions in the biomedical sciences and innovations in clinical medicine.

"The landmark contributions by these scientists who are honored with the Shaw Prize have thereby ushered in a new era in stem cell research, with huge potential benefits to mankind." said the Shaw Prize Foundation.


'/>"/>

Contact: Valerie Tucker
vtucker@gladstone.ucsf.edu
415-734-2019
Gladstone Institutes
Source:Eurekalert

Related biology news :

1. Monash researcher receives prestigious Commonwealth Health Ministers award
2. Harold Mooney wins prestigious Tyler Prize for Environmental Achievement
3. Dr. John Polanyi wins Canadas most prestigious science award
4. ESFs European ice core project EPICA receives prestigious Descartes Prize
5. PNNLs Richard Smith named to prestigious Scientific American 50 list of outstanding leaders
6. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young investigators
7. Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar
8. CIC Again Named to Software Magazines Annual Prestigious Software 500 List
9. UC Riverside biologist receives prestigious MacArthur Fellowship
10. RSC Project Prospect scoops prestigious award
11. Spradling receives Gruber Foundation Genetics Prize for new genetic techniques
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology: